MYDA Advisors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

MYDA Advisors’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-117,254	Closed	-$390K	–	194
2019 Q4	$390K	Buy	+117,254	New	+$373K	0.17%	79
2019 Q1	–	Sell	-23,000	Closed	-$83K	–	149
2018 Q4	$83K	Buy	+23,000	New	+$100K	0.14%	58

MYDA Advisors's FOMX Position: Q1 2020 in Review

MYDA Advisors sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 117,254 shares — an estimated $390K sold.

MYDA Advisors first reported a position in FOMX in Q4 2018 and held it in 2 quarters. The position peaked at $390K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

MYDA Advisors reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
MYDA Advisors sold 117,254 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $390K.
MYDA Advisors first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2018 and held it in 2 quarters.
MYDA Advisors's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $390K in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on MYDA Advisors's 13F filing for Q1 2020, filed 14 May 2020.